Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
NCT06847295

Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation

Led by University of Sao Paulo General Hospital · Updated on 2025-02-26

10

Participants Needed

1

Research Sites

258 weeks

Total Duration

On this page

Sponsors

U

University of Sao Paulo General Hospital

Lead Sponsor

M

Medtronic

Collaborating Sponsor

AI-Summary

What this Trial Is About

Spinal cord injury (SCI) is a major cause of morbidity and disability worldwide, significantly impacting patients' quality of life and functional independence. Despite advances in rehabilitation therapies, many individuals with SCI remain unable to stand or walk. Epidural electrical stimulation (EES) has emerged as a promising neuromodulation therapy to restore motor function in individuals with chronic paralysis. This prospective clinical study aims to evaluate the efficacy and safety of EES in patients with chronic SCI who have lost the ability to stand or walk. The primary objective is to assess late-stage gait recovery following the implantation of an epidural spinal cord stimulator, using validated clinical scales such as the Fugl-Meyer Assessment - Lower Extremity (FMA-LE) and BMCA VRI. Secondary objectives include evaluating: The ability to stand independently (measured by the Berg Balance Scale). Improvements in walking capacity, with or without assistance. Changes in spasticity induced by EES (Modified Ashworth Scale). Reduction in pain perception (DN4, Brief Pain Inventory \[BPI\], Pain Disability Index \[PDI\]). Improvements in neurogenic bladder and bowel dysfunction (NBSS and NBDS). Enhancements in quality of life (SCI-QOL, WHOQOL-BREF) and mood (Beck Depression Inventory \[BDI\]). The study will recruit 10 adult patients (ages 18-50) with chronic, stable SCI (≥6 months post-injury) classified as ASIA A or B, with lesions between C7 and T10 and intact segmental reflexes below the injury level. Participants will undergo an intensive 3-month pre-implant rehabilitation program to maximize their baseline motor potential. Following this period, eligible patients will receive surgical implantation of an epidural spinal cord stimulator (Medtronic Specify 5-6-5 paddle lead and Intellis pulse generator). After a 1-month post-surgical recovery period, patients will engage in a 12-month intensive rehabilitation protocol (5 supervised sessions per week), with the stimulator activated to facilitate motor recovery. Patients will be assessed monthly through clinical evaluations and surface electromyography (EMG) to measure motor control improvements. Outcomes will be compared before and after EES implantation to determine the effectiveness of the intervention. This study seeks to provide further evidence on the potential of epidural electrical stimulation in restoring standing and walking abilities in individuals with SCI. If successful, it could contribute to expanding treatment options for patients with chronic paralysis.

CONDITIONS

Official Title

Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 50 years
  • Stable spinal cord injury at least 6 months after injury
  • ASIA A or B classification with inability to stand or walk
  • Injury located between vertebral levels C7 and T10
  • Intact segmental reflexes below the injury level
  • Ability to understand and sign informed consent
  • Willingness and ability to attend daily physiotherapy sessions
  • Clinically stable overall health as assessed by investigators
Not Eligible

You will not qualify if you...

  • Use of electronic devices like baclofen pumps or cardiac pacemakers
  • Comorbidities increasing surgical risk such as anticoagulation therapy or cardiopulmonary issues
  • Locomotor deformities or other neurological disorders affecting evaluation
  • Significant dysautonomia or history of stroke or myocardial infarction linked to autonomic dysreflexia
  • MRI showing complete spinal cord transection, significant spinal atrophy, or syringomyelia
  • Uncontrolled pain, severe spasticity, or conditions limiting rehabilitation participation
  • Suspected abuse of opioids, alcohol, or illegal substances
  • Life expectancy less than 2 years due to severe malignant or clinical conditions
  • Clinically significant mental health disorders
  • Botulinum toxin injections within the past 6 months
  • Presence of voluntary lower extremity movements on EMG testing
  • Unhealed vertebral fractures
  • Presence of pressure ulcers
  • Active infection
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of São Paulo General Hospital

São Paulo, São Paulo, Brazil, 05403010

Actively Recruiting

Loading map...

Research Team

M

Matheus Moreli Porceban, MD, PhD student

CONTACT

G

Guilherme Alves Lepski, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here